pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 19·1 min read
save

Rural U.S. faces growing maternity care deserts despite falling fertility rates

Jun 19, 2026·read at STAT ↗Negative

Pregnant women in many rural parts of the United States often must travel two hours or more to reach a hospital that can deliver a baby, putting them at risk if labor starts early or complications arise.

Although the national fertility rate has dropped by about 23% over the last twenty years, the shortage of obstetricians and gynecologists is not easing. Nearly half of U.S. counties now lack a practicing OB‑GYN, creating what experts call maternity care deserts.

South Dakota illustrates the paradox: it maintains one of the country’s higher fertility rates, yet more than half of its counties are classified as maternity deserts, with no hospitals or birth centers offering obstetric services.

The authors, senior medical educators, argue that the crisis stems from how physicians are trained and deployed rather than a lack of medical knowledge or technology.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: Maternity deserts aren’t accidents. They’re the result of a design flaw”

read at STAT ↗
1,197 words · retrieved Jun 19
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
CYCLE
topics
Drug Shortage3Women's Health3OncologyPain

related stories

  • 19h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • Jun 29FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufacturingfda press
  • Jun 15Lilly scores early positive data for new JAK drugBioPharma Dive
  • May 11Dr Randall on the Rationale for Investigating CSF-1R Inhibition in TGCTonclive
  • Jun 3Legend surges on early data for ‘in vivo’ lymphoma cell therapyBioPharma Dive